Puretech Health Plc Stock Market Value
| PRTC Stock | USD 21.99 0.22 0.99% |
| Symbol | PureTech |
PureTech Health PLC Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (3.00) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.91) | Return On Assets (0.13) |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PureTech Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PureTech Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PureTech Health.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in PureTech Health on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding PureTech Health PLC or generate 0.0% return on investment in PureTech Health over 720 days. PureTech Health is related to or competes with Molecular Partners, MediciNova, Anebulo Pharmaceuticals, Champions Oncology, Eliem Therapeutics, Opthea, and Acrivon Therapeutics,. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inf... More
PureTech Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PureTech Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PureTech Health PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 14.97 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 4.06 |
PureTech Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PureTech Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PureTech Health's standard deviation. In reality, there are many statistical measures that can use PureTech Health historical prices to predict the future PureTech Health's volatility.| Risk Adjusted Performance | 9.0E-4 | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PureTech Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PureTech Health PLC Backtested Returns
At this point, PureTech Health is very steady. PureTech Health PLC maintains Sharpe Ratio (i.e., Efficiency) of 0.0225, which implies the firm had a 0.0225% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for PureTech Health PLC, which you can use to evaluate the volatility of the company. Please check PureTech Health's Risk Adjusted Performance of 9.0E-4, coefficient of variation of (11,141), and Variance of 11.27 to confirm if the risk estimate we provide is consistent with the expected return of 0.0742%. PureTech Health has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.9, which implies possible diversification benefits within a given portfolio. PureTech Health returns are very sensitive to returns on the market. As the market goes up or down, PureTech Health is expected to follow. PureTech Health PLC right now holds a risk of 3.3%. Please check PureTech Health PLC kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if PureTech Health PLC will be following its historical price patterns.
Auto-correlation | 0.29 |
Poor predictability
PureTech Health PLC has poor predictability. Overlapping area represents the amount of predictability between PureTech Health time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PureTech Health PLC price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current PureTech Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 11.02 |
PureTech Health PLC lagged returns against current returns
Autocorrelation, which is PureTech Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PureTech Health's stock expected returns. We can calculate the autocorrelation of PureTech Health returns to help us make a trade decision. For example, suppose you find that PureTech Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PureTech Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PureTech Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PureTech Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PureTech Health stock over time.
Current vs Lagged Prices |
| Timeline |
PureTech Health Lagged Returns
When evaluating PureTech Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PureTech Health stock have on its future price. PureTech Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PureTech Health autocorrelation shows the relationship between PureTech Health stock current value and its past values and can show if there is a momentum factor associated with investing in PureTech Health PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out PureTech Health Correlation, PureTech Health Volatility and PureTech Health Alpha and Beta module to complement your research on PureTech Health. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
PureTech Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.